Tilray expanded its medical cannabis portfolio in Australia, but market weakness overshadows the company’s push into a key growth market.
Importance Rank:
1
Tilray expanded its medical cannabis portfolio in Australia, but market weakness overshadows the company’s push into a key growth market.